Browse drugs

…rtension, osteoarthritis and previous stroke for which she took clopidogrel daily.…

…rction. The patient was initiated on dual antiplatelet therapy (aspirin 325 mg daily and clopidogrel 75 mg daily) for secondary stroke …

…irmed with carotid duplex. The patient was started on DAPT with aspirin, clopidogrel and subsequently underwent left ICA cervical segme…

…lications (TECs). Recently, newer-generation P2Y12 inhibitors - prasugrel and ticagrelor (PSG/TCG) - have emerged as potential alternativ…

… was administered with transition to dual antiplatelet therapy (aspirin 40.5 mg and clopidogrel 10 mg daily). Final angiography demonst…

…ebral artery. Both patients received dual antiplatelet therapy (aspirin 81 mg, clopidogrel 75 mg). A structured, patient-reported outco…

… lower mortality at 6 months, 1 year, and 3 years compared with alteplase, without increased intracerebral hemorrhage. Early cognitive im…

…l consequences. Mandatory dual antiplatelet therapy (DAPT) with aspirin and clopidogrel mitigates this risk but creates significant man…

… administration, and monitoring considerations are provided for aspirin, clopidogrel, prasugrel, ticagrelor, cangrelor, and glycoprotei…

… established criteria for prasugrel use (CRUSADE score ≤40) and clopidogrel for higher scores or medically managed patients. A proforma wit…

…and a non-vitamin K antagonist OAC. In this patient population, clopidogrel is the P2Y12 inhibitor of choice given the significantly lower …

…s given in 20 (96%) of patients, with one patient on short term clopidogrel and DOAC, followed by DOAC alone. One (3.7%) peri-procedural co…